UPDF AI

The neuroleptic malignant syndrome in an adolescent.

S. Merry,J. Werry,A. Merry,N. Birchall

1986 · DOI: 10.1016/S0002-7138(09)60240-5
Journal of the American Academy of Child Psychiatry · 18 Citations

TLDR

A case of the neuroleptic malignant syndrome in a 14-year-old schizophrenic boy receiving 60 mg (1 mg/kg) trifluoperazine daily, is described, demonstrating the possibility of its occurrence and the need for awareness of the syndrome.